A Case of Severe Aplastic Anemia in a 35-Year-Old Male With a Good Response to Immunosuppressive Therapy
- PMID: 37435252
- PMCID: PMC10332331
- DOI: 10.7759/cureus.40210
A Case of Severe Aplastic Anemia in a 35-Year-Old Male With a Good Response to Immunosuppressive Therapy
Abstract
Aplastic anemia (AA) is a severe but rare hematologic condition associated with hematopoietic failure leading to decreased or total absent hematopoietic precursor cells in the bone marrow. AA presents at any age with equal distribution among gender and race. There are three known mechanisms of AA: direct injuries, immune-mediated disease, and bone marrow failure. The most common etiology of AA is considered to be idiopathic. Patients usually present with non-specific findings, such as easy fatigability, dyspnea on exertion, pallor, and mucosal bleeding. The primary treatment of AA is to remove the offending agent. In patients in whom the reversible cause was not found, patient management depends on age, disease severity, and donor availability. Here, we present a case of a 35-year-old male who presented to the emergency room with profuse bleeding after a deep dental cleaning. He was found to have pancytopenia on his laboratory panel and had an excellent response to immunosuppressive therapy.
Keywords: anti-thymocyte globulin (atg); eltrombopag; hypocellular bone marrow; paroxysmal nocturnal hemoglobinuria (pnh); severe aplastic anemia.
Copyright © 2023, Proskuriakova et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Special Education: Aplastic Anemia.Oncologist. 1996;1(3):187-189. Oncologist. 1996. PMID: 10387986
-
Two Roads Diverge: Treatment Choice in Coexisting Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.J Med Cases. 2020 Jun;11(6):182-184. doi: 10.14740/jmc3478. Epub 2020 May 28. J Med Cases. 2020. PMID: 34434393 Free PMC article.
-
Idiopathic Aplastic anemia: Indian Perspective.Indian J Hematol Blood Transfus. 2023 Jul;39(3):357-370. doi: 10.1007/s12288-022-01592-4. Epub 2022 Oct 31. Indian J Hematol Blood Transfus. 2023. PMID: 37304471 Free PMC article. Review.
-
Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.Expert Rev Hematol. 2014 Dec;7(6):775-89. doi: 10.1586/17474086.2014.967678. Epub 2014 Oct 21. Expert Rev Hematol. 2014. PMID: 25331515 Review.
-
Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.Ann Intern Med. 1999 Sep 21;131(6):401-8. doi: 10.7326/0003-4819-131-6-199909210-00002. Ann Intern Med. 1999. PMID: 10498555
Cited by
-
A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Severely Underweight Patient with Aplastic Anemia.Case Rep Hematol. 2024 Mar 4;2024:2044820. doi: 10.1155/2024/2044820. eCollection 2024. Case Rep Hematol. 2024. PMID: 38469371 Free PMC article.
References
-
- Aplastic anaemia: current concepts in diagnosis and management. Furlong E, Carter T. J Paediatr Child Health. 2020;56:1023–1028. - PubMed
-
- Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group. Issaragrisil S, Sriratanasatavorn C, Piankijagum A, et al. https://pubmed.ncbi.nlm.nih.gov/2029577/ Blood. 1991;77:2166–2168. - PubMed
-
- Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up. Saracco P, Quarello P, Iori AP, et al. Br J Haematol. 2008;140:197–205. - PubMed
-
- Epidemiology of aplastic anemia: a prospective multicenter study. Montané E, Ibáñez L, Vidal X, Ballarín E, Puig R, García N, Laporte JR. Haematologica. 2008;93:518–523. - PubMed
Publication types
LinkOut - more resources
Full Text Sources